Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 177-187 , Summer 2009

Photodynamic Therapy as an Innovative Treatment for Malignant Pleural Mesothelioma

  • Joseph S. Friedberg, MD, FACS

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Joseph S. Friedberg, MD, FACS, University of Pennsylvania Medical Center–Presbyterian, 51 North 39th Street, 250 Wright-Saunders Building, Philadelphia, PA 19104

References 

  1. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–1603
  2. Sugarbaker DJ. Macroscopic complete resection: The goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol. 2006;1:175–176
  3. Zellos L, Richards WG, Capalbo L, et al. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2009;137:453–458
  4. Mujoomdar AA, Sugarbaker DJ. Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2008;20:298–304
  5. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889–905
  6. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387
  7. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508
  8. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 2002;62:1604–1608
  9. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6:535–545
  10. Korbelik M, Stott B, Sun J. Photodynamic therapy-generated vaccines: Relevance of tumour cell death expression. Br J Cancer. 2007;97:1381–1387
  11. DeArmond DT, Mahtabifard A, Fuller CB, et al. Photodynamic therapy followed by thoracoscopic sleeve lobectomy for locally advanced lung cancer. Ann Thorac Surg. 2008;85:e24–e26
  12. Loewen GM, Pandey R, Bellnier D, et al. Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med. 2006;38:364–370
  13. Ross P, Grecula J, Bekaii-Saab T, et al. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. Lasers Surg Med. 2006;38:881–889
  14. Usuda J, Kato H, Okunaka T, et al. Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol. 2006;1:489–493
  15. Tokar JL, Haluszka O, Weinberg DS. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. Semin Radiat Oncol. 2007;17:10–21
  16. Chen M, Pennathur A, Luketich JD. Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers Surg Med. 2006;38:396–402
  17. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30:264–271
  18. Wang KK, Lutzke L, Borkenhagen L, et al. Photodynamic therapy for Barrett's esophagus: Does light still have a role?. Endoscopy. 2008;40:1021–1025
  19. Cruess AF, Zlateva G, Pleil AM, et al. Photodynamic therapy with verteporfin in age-related macular degeneration: A systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol. 2009;87:118–132
  20. Keam SJ, Scott LJ, Curran MP. Verteporfin: A review of its use in the management of subfoveal choroidal neovascularisation. Drugs. 2003;63:2521–2554
  21. Mennel S, Barbazetto I, Meyer CH, et al. Ocular photodynamic therapy—Standard applications and new indications (Part 1) (Review of the literature and personal experience). Ophthalmologica. 2007;221:216–226
  22. Ascencio M, Collinet P, Cosson M, et al. (The place of photodynamic therapy in gynecology). Gynecol Obstet Fertil. 2007;35:1155–1165
  23. Witjes JA. Management of BCG failures in superficial bladder cancer: A review. Eur Urol. 2006;49:790–797
  24. Lorenz KJ, Maier H. (Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan). HNO. 2008;56:402–409
  25. Rodriguez E, Baas P, Friedberg JS. Innovative therapies: Photodynamic therapy. Thorac Surg Clin. 2004;14:557–566
  26. Friedberg JS, Mick R, Stevenson JP, et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol. 2004;22:2192–2201
  27. Friedberg JS, Mick R, Stevenson J, et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg. 2003;75:952–959
  28. Ferrario A, Rucker N, Wong S, et al. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res. 2007;67:4989–4995
  29. Pass HI, Pogrebniak H. Photodynamic therapy for thoracic malignancies. Semin Surg Oncol. 1992;8:217–225
  30. Pass HI, Tochner Z, DeLaney T, et al. Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg. 1990;50:687–688
  31. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleural photodynamic therapy: Results of a phase I trial. Ann Surg Oncol. 1994;1:28–37
  32. Pass HI, Temeck BK, Kranda K, et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997;4:628–633
  33. Ferrario A, Gomer CJ. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. J Environ Pathol Toxicol Oncol. 2006;25:251–259
  34. Friedberg JS, Skema C, Burdick J, et al. A novel technique for light delivery through branched or bent anatomic structures. J Thorac Cardiovasc Surg. 2003;126:1963–1967

PII: S1043-0679(09)00076-8

doi: 10.1053/j.semtcvs.2009.07.001

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 177-187 , Summer 2009

Article Tools

* Image Usage & Resolution